OpenVSafe by OpenVAERS
Search V-safe

4Y7-14441-84533

1 vaccination 3 coded responses 3 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
117 / NY
Registered
2021-05-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-08
    Registered in v-safe
  3. 2021-05-08
    Survey response — day 35, dose 1
    MedDRA: Hospitalisation, Neurological symptom — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Adverse neurological symptoms since the first vaccine, resulted in 2 hospital stays. Was advised by both not to go back for the 2nd vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-05-08
    Report sent to call center — day 35, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  5. 2021-05-10
    Survey response — day 42, dose 1
    MedDRA: Arthralgia, Balance disorder, Chest pain, Fatigue, Loss of personal independence in daily activities, Mastication disorder, Mobility decreased, Muscle spasms, Myalgia, Paraesthesia, Speech disorder, Vision blurred — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Extreme fatigue, muscle/joint pain, pins & needles in arms/legs, blurred vision/off balance, spasms, chest pain. Speech/chewing difficulty. Cannot do daily activities/climb stairs. Told by hospital(s) not to get 2nd vaccine due to adverse reaction.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-05-10
    Report sent to call center — day 42, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-06-08
  8. 2021-06-28
    Survey response — 3 months, dose 1
    MedDRA: Neurological symptom, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Symptoms: Continued neurological problems · Healthcare visit (other): In April
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-06-28
    Report sent to call center — 3 months, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-07-01
  11. 2022-02-28
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

DoseDateManufacturerCo-administered
12021-03-29Pfizer-BioNTech

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 8 — day 35, dose 1

2021-05-08

Symptoms: Adverse neurological symptoms since the first vaccine, resulted in 2 hospital stays. Was advised by both not to go back for the 2nd vaccine.

Release 8 — day 42, dose 1

2021-05-10

Symptoms: Extreme fatigue, muscle/joint pain, pins & needles in arms/legs, blurred vision/off balance, spasms, chest pain. Speech/chewing difficulty. Cannot do daily activities/climb stairs. Told by hospital(s) not to get 2nd vaccine due to adverse reaction. cut off by CDC

Release 9 — 3 months, dose 1

2021-06-28

Symptoms: Continued neurological problems
Healthcare visit (other): In April

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDArthralgia ✓ ✓ ✓
SDBalance disorder ✓ ✓ ✓
SDChest pain ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHospitalisation ✓ ✓ ✓
SDLoss of personal independence in daily activities ✓ ✓ ✓
SDMastication disorder ✓ ✓ ✓
SDMobility decreased ✓ ✓ ✓
SDMuscle spasms ✓ ✓ ✓
SDMyalgia ✓ ✓ ✓
SDNeurological symptom ✓ ✓ ✓
SDParaesthesia ✓ ✓ ✓
SDSpeech disorder ✓ ✓ ✓
SDVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release